FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for Vagifem (estradiol) by Novo Nordisk. This action updates the product labeling for the vaginal estrogen therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Menopause
• Vaginal Atrophy

Drugs mentioned

• Vagifem (Estradiol)

Snippet

SUPPL AP for VAGIFEM (ESTRADIOL)